• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 2, 2017

View Archived Issues

Phase II data from IPROTECT1 trial presented for VAC-3S anti-HIV1 vaccine

Read More

AbbVie presents key events from the second quarter 2017

Read More

Astellas recaps pipeline highlights of first quarter of fiscal 2017

Read More

IMMU-132 induces durable responses in heavily pretreated patients with metastatic NSCLC

Read More

Shionogi reviews key regulatory and pipeline events of first quarter of fiscal 2017

Read More

FDA approves Nityr tablets for treatment of hereditary tyrosinemia type 1

Read More

Phase III trial shows HIV suppression with bictegravir/emtricitabine/tenofovir coformulation

Read More

Muscarinic M1 receptor modulator from Suven has no cholinergic side effects in animal models

Read More

First patient treated in phase II trial of Acceleron Pharma's ACE-083

Read More

Aptinyx begins phase II studies of NYX-2925

Read More

French researchers patent compounds for treating cancer

Read More

FDA awards fast track designation to oral pritelivir for HSV in immunocompromised adults

Read More

Celgene identifies antiproliferative compounds for AML

Read More

Arcus Biosciences divulges CD73 inhibitors

Read More

Teva presents laquinimod prodrugs for multiple sclerosis

Read More

Soluble guanylate cyclase activators presented by Bayer

Read More

Rockefeller University divulges FXIIa inhibitors

Read More

Lundbeck joins large study of genetic causes of MDD and bipolar depression

Read More

Wakamoto begins phase II study of WP-1303 in Japan

Read More

FDA approves Opdivo for MSI-H and dMMR metastatic colorectal cancer

Read More

Integrated BioTherapeutics obtains funding to develop pan-ebolavirus vaccine

Read More

Cellectar Biosciences enters collaboration with Avicenna Oncology

Read More

FDA grants priority review to acalabrutinib NDA

Read More

NeuroDerm to hold extraordinary shareholder meeting regarding acquisition by Mitsubishi Tanabe

Read More

Amygdala Neurosciences initiates phase Ib study of ALDH2 inhibitor

Read More

TG Therapeutics, FDA reach agreement on phase III studies of TG-1101

Read More

FDA approves Idhifa for R/R AML with IDH2 mutation

Read More

FDA approves Epclusa for use in hepatitis C patients co-infected with HIV

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 16, 2025.
  • Art concept for bladder

    Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA

    BioWorld
    During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 10, 2025
  • Red blood cells in an artery with cholesterol

    In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol

    BioWorld
    In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe